MELONY FOWLER: Open Payments
NPI 1013267558 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,309 in 61 payments from 15 companies in 2025. Trend: 2023 $1,151 · 2024 $1,202 · 2025 $1,309
Food & beverage: $1,125Education: $184
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $389 |
| ABBVIE INC. | 12 | $257 |
| Madrigal Pharmaceuticals | 6 | $118 |
| Ardelyx, Inc. | 5 | $105 |
| GENZYME CORPORATION | 3 | $79 |
| Phathom Pharmaceuticals, Inc. | 5 | $64 |
| Regeneron Healthcare Solutions, Inc. | 2 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $50 |
| Organon LLC | 2 | $46 |
| QOL Medical, LLC | 2 | $34 |
Products named: TREMFYA, RINVOQ, DUPIXENT, REZDIFFRA, IBSRELA, VOQUEZNA, HADLIMA, SKYRIZI.
Industry payments across SC — which companies pay providers there.
